Introduction
BLNK, also known as B-cell linker, is a cytoplasmic adaptor protein crucial for B cell development. It plays a vital role in linking B cell receptor activation to downstream signaling pathways, influencing various cellular functions. Upon B cell receptor stimulation, BLNK interacts with effector proteins like GRB2, Vav, NCK, and PLC-g. Phosphorylation of BLNK by Syk tyrosine kinase facilitates the activation of these downstream effectors. Genetic mutations in the BLNK gene can lead to hypoglobulinemia and absent B cells, characterized by a developmental block in the pro- to pre-B-cell transition. BLNK protein deficiency is also observed in certain cases of pre-B acute lymphoblastic leukemia.
Description
Recombinant human BLNK protein is produced in E. coli with an N-terminal His tag (20 amino acids). This protein is a single, non-glycosylated polypeptide chain comprising 476 amino acids (residues 1-456) with a molecular weight of 52.6 kDa. Note that the protein may appear larger on SDS-PAGE due to the His tag. Purification is achieved using proprietary chromatographic techniques.
Physical Appearance
A clear, colorless solution that has been sterilized by filtration.
Formulation
The BLNK protein is provided as a 1 mg/ml solution in a buffer consisting of 20mM Tris-HCl (pH 8.0), 20% glycerol, 0.1M NaCl, 1mM DTT, and 0.1mM PMSF.
Stability
For short-term storage (up to 4 weeks), the BLNK solution can be stored at 4°C. For extended storage, it is recommended to freeze the solution at -20°C. The addition of a carrier protein (0.1% HSA or BSA) is advised for long-term storage. Avoid repeated freezing and thawing cycles.
Purity
The purity of BLNK is greater than 90% as determined by SDS-PAGE analysis.
Synonyms
B-cell linker protein, B-cell adapter containing a SH2 domain protein, B-cell adapter containing a Src homology 2 domain protein, Cytoplasmic adapter protein, Src homology 2 domain-containing leukocyte protein of 65 kDa, SLP-65, BLNK, BASH, SLP65, AGM4, LY57, BLNK-S, MGC111051.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MDKLNKITVP ASQKLRQLQK MVHDIKNNEG GIMNKIKKLK VKAPPSVPRR DYASESPADE EQQWSDDFDS DYENPDEHSD SEMYVMPAEE NADDSYEPPP VEQETRPVHP ALPFARGEYI DNRSSQRHSP PFSKTLPSKP SWPSEKARLT STLPALTALQ KPQVPPKPKG LLEDEADYVV PVEDNDENYI HPTESSSPPP EKAPMVNRST KPNSSTPASP PGTASGRNSG AWETKSPPPA APSPLPRAGK KPTTPLKTTP VASQQNASSV CEEKPIPAER HRGSSHRQEA VQSPVFPPAQ KQIHQKPIPL PRFTEGGNPT VDGPLPSFSS NSTISEQEAG VLCKPWYAGA CDRKSAEEAL HRSNKDGSFL IRKSSGHDSK QPYTLVVFFN KRVYNIPVRF IEATKQYALG RKKNGEEYFG SVAEIIRNHQ HSPLVLIDSQ NNTKDSTRLK YAVKVS.